Therapies
Friday, August 10th, 2012
American College of Cardiology Foundation: August 9, 2012 This analysis aimed to evaluate the association of statin exposure and incident diabetes, and subsequent outcomes in the general population. Background Cardiovascular events as consequences of atherosclerosis and diabetes are reduced by statins. However, statins are associated with excessive risk of diabetes occurrence according to clinical trial analyses. From […]
Therapies
Friday, August 10th, 2012
Fda.gov: Aug. 8, 2012 The U.S. Food and Drug Administration today approved changes to the labeling for the Stryker Wingspan Stent System, including the indications for use. These changes, which the FDA outlined in a safety communication also issued today, specify a more limited group of patients who may benefit from the system. In addition, the safety communication […]
Therapies
Friday, August 10th, 2012
American Heart Association: August 7, 2012 Background and Purpose—Endothelin is considered to be a key mediator of vasospasm after subarachnoid hemorrhage. A meta-analysis of randomized trials on the effectiveness of endothelin receptor antagonists in subarachnoid hemorrhage has been published previously, but since then new major trials have been published. We present the results of a systematic […]
Therapies
Friday, August 10th, 2012
Biomedcentral.com: Published: 26 July 2012 An observational study to examine whether thrombolytic therapy in stroke patients realizes better quality of life outcomes compared to patients without thrombolytic therapy one year after stroke. We also examined whether daily functioning, mental functioning and activities improved after thrombolytic treatment. Subjects: A total of 88 stroke patients were interviewed at […]
Therapies
Friday, August 10th, 2012
Journal of Cerebral Blood Flow & Metabolism: 7/18/12 Recombinant tissue plasminogen activator (tPA) is the only approved medication in acute ischemic stroke. However, <20% of all stroke patients receive tPA (Weimar et al, 2006), a situation mainly owed to the narrow treatment time window of 4.5 hours. Another significant limitation of tPA is bleeding-related adverse events. Moreover, as […]
Therapies
Tuesday, August 7th, 2012
Onlinelibrary.wiley.com 8/1/12 Twelve million people develop ischemic stroke each year world over and 30–40% of them do not have arterial occlusions at presentation. Trials conducted to study the efficacy of thrombolytic drug reported better outcome with use of thrombolytic drug but none studied the subtypes of ischemic strokes specifically and adequately. The subgroups of […]
Therapies
Tuesday, August 7th, 2012
Stroke.ahajournals.org: July 31, 2012 The purpose of this study was to evaluate safety and efficacy of the Solitaire FR device in the treatment of patients with acute ischemic stroke secondary to large artery occlusion. Methods—We conducted a retrospective study of consecutive patients presenting with acute ischemic stroke treated with Solitaire FR as the first-line device to […]
Therapies
Tuesday, August 7th, 2012
Prnewswire.com: 7/2712 Results Announced at Society of NeuroInterventional Surgery (SNIS) 9th Annual Meeting SAN DIEGO, July 27, 2012 /PRNewswire-USNewswire/ — Endovascular therapy (EVT) is associated with significantly better treatment outcomes over traditional intravenous tPA (IVT) for patients suffering acute ischemic stroke resulting from blockages in the large vessels, or major “highways” of the brain, according to a study presented […]
Therapies
Friday, July 27th, 2012
Prnewswire.com: 7/24/12. The Society of Neurointerventional Surgery (SNIS) 9th Annual Meeting opened with study results which show that patients presenting with ischemic stroke may be successfully treated with endovascular or minimally invasive therapy well beyond the 8-hour treatment window today considered standard by most neurointerventional practitioners. The multi-center study evaluated the use of computed tomography (CT) perfusion […]
Therapies
Friday, July 27th, 2012
News-medical.net: 7/20/12. Results of the randomized ACT NoW trial show no benefit of “enhanced” over “everyday” communication therapy for patients with dysarthria resulting from stroke. Overall, communicative ability in the 170 patients in ACT NoW (Assessing Communication Therapy in the North West) improved over the study period, from a baseline average of 2.4 points on the […]
